P12. Placental gene expression analysis at the end of the first trimester of pregnancy in patients at high risk of subsequent development of preeclampsia [0.03%]
高风险子痫前期患者妊娠第一孕期结束时胎盘基因表达分析
Ulrik Dolberg Anderson,M D Baskaran Thilaganathan,Stefan R Hansson
Ulrik Dolberg Anderson
P13. Alterations in placental expression of Caveolin-1, Cavin-1 and eNOS in women with pre-eclampsia [0.03%]
子痫妇女胎盘Caveolin-1、Cavin-1和eNOS表达的改变
Kate Smith-Jackson,Anna N Czajka,Lesia O Kurlak et al.
Kate Smith-Jackson et al.
P11. Differentially expressed micro-RNAs in microparticles from haemoglobin perfused placentas [0.03%]
在血红蛋白灌注胎盘的微粒中差异表达的Micro-RNA
T Rasmussen,K May,M Familari et al.
T Rasmussen et al.
P10. Placental expression of haemostatic and angiogenic markers in preeclampsia [0.03%]
子痫前期胎盘止血和促血管生成标志物的表达研究
Lynne Kelly,Shanthi Muttukrishna,Lucy Norris et al.
Lynne Kelly et al.
P9. The elecsys assay for PlGF, sFlt1 and their ratio (sFlt1/PlGF) as an aid in differential diagnosis of pregnancy-related hypertensive disorders [0.03%]
P9. Elecsys对PlGF，sFlt1及其比值(sFlt1 / PlGF)测定作为妊娠相关高血压疾病鉴别诊断的辅助手段
T Engels,J Pape,K Schoofs et al.
T Engels et al.
A Molvarec,A Szarka,B Stenczer et al.
A Molvarec et al.
P7. Role of EGF-like domain 7 (Egfl7) in placental development and implantation [0.03%]
P7.EGF样结构域7(Egfl7)在胎盘发育和着床中的作用
Silvia Salvi,Sergio Ferrazzani,Lucia Vecchione et al.
Silvia Salvi et al.
P6. Active and inactivated hemopexin in pregnancy and preeclampsia: Do they activate monocytes and endothelial cells? [0.03%]
妊娠和子痫前期的活跃及失活血红素结合蛋白：它们会激活单核细胞和内皮细胞吗？
F Spaans,C Chiang,W W Bakker et al.
F Spaans et al.
P5. Bioinformatic analysis of protein-protein interaction network in preeclampsia [0.03%]
子痫蛋白-蛋白相互作用网络的生物信息学分析
E Tejera,J Bernardes,I Rebelo
E Tejera
P4. Uteroplacental arterio-venosus difference in sFlt, but not in endoglin concentrations in preeclampsia [0.03%]
子痫前期胎盘子宫动静脉sFlt差异，但endoglin浓度无差别
M C P Roland,B Lorentzen,K Godang et al.
M C P Roland et al.